Milestone Scientific (MLSS) Current Deferred Revenue (2014 - 2019)

Milestone Scientific (MLSS) has 5 years of Current Deferred Revenue data on file, last reported at $259000.0 in Q4 2019.

• For the quarter ending Q4 2019, Current Deferred Revenue rose 159.0% year-over-year to $259000.0; the trailing twelve-month figure through Dec 2019 stood at $259000.0 (up 159.0% YoY), and the FY2019 full-year result was $259000.0, up 159.0% from the prior year.
• Current Deferred Revenue climbed to $259000.0 in Q4 2019, from $50000.0 in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $2.8 million in Q2 2018 to a low of $50000.0 in Q1 2019.
• A 4-year average of $942207.7 and a median of $712800.0 in 2017 frame the typical range for Current Deferred Revenue.
• Across the five-year window, Current Deferred Revenue soared 690.68% in 2018 and tumbled 97.1% in 2019, its largest moves.
• Tracing MLSS's Current Deferred Revenue over 4 years: stood at $1.0 million in 2016, then jumped by 72.23% to $1.7 million in 2017, then plunged by 94.2% to $100000.0 in 2018, then surged by 159.0% to $259000.0 in 2019.
• Business Quant data shows MLSS's Current Deferred Revenue at $259000.0 in Q4 2019, $50000.0 in Q1 2019, and $100000.0 in Q4 2018.